Outcomes by cytogenetic and molecular response at 12 and 18 months of imatinib in patients with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP) in the IRIS trial

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Baccarani M, Guilhot F, Larson RA, O'Brien SG, Druker BJ, IRIS Study Grp

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Blood: 48th Annual Meeting of the American Society of Hematology

Year of Conference: 2006

Pages: 606A no. 2138

ISSN: 0006-4971

Publisher: American Society of Hematology

URL: http://abstracts.hematologylibrary.org/cgi/content/abstract/108/11/2138

Library holdings: Search Newcastle University Library for this item

ISBN: 15280020

ePrints